Detalles de la búsqueda
1.
The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results.
Future Oncol
; 20(1): 5-16, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37916267
2.
Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer.
Oncologist
; 28(5): 414-424, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36952230
3.
Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?
Curr Treat Options Oncol
; 24(9): 1120-1137, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37428332
4.
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel.
Oncologist
; 27(9): 722-731, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704278
5.
Impact of genomic assays on treatment and outcomes in locally advanced breast cancer.
Breast Cancer Res Treat
; 194(2): 433-447, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35635580
6.
Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2-negative advanced breast cancer from the United States, Europe, and Israel.
BMC Cancer
; 22(1): 1343, 2022 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36550413
7.
A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis.
Support Care Cancer
; 30(7): 6135-6144, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35426046
8.
A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices.
Support Care Cancer
; 30(10): 7913-7922, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35732748
9.
Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group.
Oncologist
; 26(8): 651-659, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33650740
10.
A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application.
Breast Cancer Res Treat
; 187(1): 113-124, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428072
11.
Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safety.
BMC Cancer
; 21(1): 621, 2021 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34044798
12.
MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial.
BMC Cancer
; 20(1): 81, 2020 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32005181
13.
Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients.
Breast Cancer Res Treat
; 176(2): 253-260, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30900138
14.
Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG).
Breast Cancer Res Treat
; 171(1): 11-20, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29725889
15.
Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG).
Breast Cancer Res Treat
; 169(1): 1-7, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29352368
16.
Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature.
Breast Cancer Res Treat
; 153(3): 617-24, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26358708
17.
A role for fulvestrant monotherapy in the first-line treatment of ER+ metastatic breast cancer?
Breast J
; 26(2): 109-111, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31538681
18.
A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer.
Breast Cancer Res Treat
; 146(1): 7-14, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24899084
19.
An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?
Expert Rev Neurother
; 24(1): 77-103, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38145503
20.
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer.
J Clin Oncol
; : JCO2301940, 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38513188